INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.००
arrow_upward
+१.००%(+०.००९९) 1D
US$ १.०२
arrow_upward
+२.००% (+०.०२०)todayPre-market
Closed: अक्टोबर १९, १६:००:०१ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.०१
High
US$ १.०२
Low
US$ ०.९८
Mkt. cap
१०.३४ करोड
Avg. vol.
२८.७१ लाख
Volume
१.६३ हजार
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
Open
US$ १.०१
High
US$ १.०२
Low
US$ ०.९८
Mkt. cap
१०.३४ करोड
Avg. vol.
२८.७१ लाख
Volume
१.६३ हजार
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
News stories
From web sources and news partners
TradingView
·
१ घण्टा पहिले
Asia’s Bitcoin Play Hits Wall Street: Metaplanet Set to Buy This Nasdaq-Listed Company for BTC Treasury Operations
The Motley Fool
·
११ मिनेट पहिले
IVV vs. SPY: Which S&P 500 ETF Is the Better Buy for Long-Term Investors?
Yahoo Finance
·
४४ मिनेट पहिले
Should You Wait Until After the Midterm Elections to Buy the S&P 500?
CNBC
·
७ घण्टा पहिले
CNBC Daily Open: Tech investors buy the dip — but debt remains a concern
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc